Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-68.29	20.34	64.13
Graham Fair Price	268.06	6.97	1.89
PEG	-99.50	< 0.005	1.10
Price/Book	-11.77	0.95	1.08
Price/Cash Flow	1055.00	115.65	10.01
Prices/Earnings	-93.80	8.20	-132.37
Price/Sales	17.44	1.95	1.66
Price/FCF	1055.00	115.65	10.01
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	63.82	0.15	0.09
Operating Margin	2668.48	0.07	< 0.005
ROA	1288.25	0.02	< 0.005
ROE	< 0.005	0.03	1323.98
ROIC	< 0.005	0.02	1126.82
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	30.02	0.08	39128.77
Dividends QOQ	-1.00	-0.19	81.10
EBIT QOQ	-0.87	20.42	2245.52
EPS QOQ	-1.21	14.89	1133.41
FCF QOQ	32.68	-0.92	-97.18
Revenue QOQ	-0.07	-0.23	-237.85
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	39.87	59.51	49.26
Days Sales Outstanding (DSO)	79.48	111.20	39.91
Inventory Turnover	2.26	1.51	-33.00
Debt/Capitalization	< 0.005	0.14	2502.89
Quick Ratio	2.15	2.02	-5.83
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	8.84	8.62	-2.46
Cash	2.68	2.56	-4.41
Capex	< 0.005	-0.01	-58.47
Free Cash Flow	0.95	0.07	-92.55
Revenue	5.75	4.21	-26.72
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.91	2.77	-4.78
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-22.04	-3.33	84.90
Naive Interpretation	Member

06 - Financial Health · Bad

Rating